Showing results (681-690 of 809) with videos related to

Sort By:
Pageof 81
Plos One|August 28, 2015
Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
Oncogene|September 13, 2019
An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteasesDi Chen, Zhen Ning, Huan Chen, et al.
BMC Cancer|September 13, 2019
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patientsXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
Plos One|November 8, 2007
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyJiang Li, Xue-hui Zeng, Hao-yuan Mo, et al.
Medical Oncology (Northwood, London, England)|July 16, 2014
Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinomaRou Jiang, Zhong-Han Yang, Dong-Hua Luo, et al.
Cancer Research and Treatment|January 18, 2019
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment GuidanceXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
Medicine|September 3, 2020
Observation on the clinical effect of thunder-fire moxibustion combined with acupressure on ocular muscle spasm: A clinical randomized controlled trialYi-Fei Cao, Tie-Jun Li, Yong-Mei Xu, et al.
Oncotarget|October 30, 2015
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinomaWen-Hui Chen, Lin-Quan Tang, Lu Zhang, et al.
BMC Cancer|January 23, 2019
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapyXue-Song Sun, Li-Ting Liu, Sai-Lan Liu, et al.
The Oncologist|June 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinomaYi-Fu Li, Yu Chen, Hui Cheng, et al.
Pageof 81